MRTX Mirati Therapeutics, Inc. Stock Quote

MRTX [NASD]

Index	-	P/E	-	EPS (ttm)	-7.70	Insider Own	0.60%	Shs Outstand	48.61M	Perf Week	-1.85%
Market Cap	9.84B	Forward P/E	-	EPS next Y	-7.46	Insider Trans	-75.41%	Shs Float	45.73M	Perf Month	3.40%
Income	-329.20M	PEG	-	EPS next Q	-2.15	Inst Own	97.30%	Short Float	7.52%	Perf Quarter	-10.07%
Sales	12.20M	P/S	806.15	EPS this Y	-39.80%	Inst Trans	10.57%	Short Ratio	8.10	Perf Half Y	34.93%
Book/sh	27.99	P/B	7.18	EPS next Y	16.30%	ROA	-41.20%	Target Price	245.92	Perf Year	138.03%
Cash/sh	28.40	P/C	7.08	EPS next 5Y	-	ROE	-45.10%	52W Range	66.01 - 249.42	Perf YTD	-8.52%
Dividend	-	P/FCF	-	EPS past 5Y	-15.80%	ROI	-27.10%	52W High	-19.45%	Beta	1.47
Dividend %	-	Quick Ratio	19.60	Sales past 5Y	-	Gross Margin	-	52W Low	204.38%	ATR	9.35
Employees	201	Current Ratio	19.60	Sales Q/Q	240.00%	Oper. Margin	-	RSI (14)	45.98	Volatility	4.69% 4.85%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-13.40%	Profit Margin	-	Rel Volume	1.24	Prev Close	195.60
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	424.78K	Price	200.92
Recom	2.30	SMA20	-0.96%	SMA50	-5.80%	SMA200	18.34%	Volume	527,421	Change	2.72%

Dec-08-20

Initiated

JMP Securities

Mkt Perform

Dec-08-20

Initiated

Evercore ISI

Outperform

Nov-17-20

Downgrade

BofA Securities

Neutral → Underperform

$196

Nov-10-20

Downgrade

Jefferies

Buy → Hold

$206 → $208

Nov-10-20

Downgrade

Guggenheim

Buy → Neutral

$230

Nov-09-20

Reiterated

H.C. Wainwright

Buy

$233 → $265

Sep-28-20

Initiated

BofA Securities

Neutral

$172

Sep-18-20

Downgrade

Citigroup

Buy → Neutral

$127 → $183

May-01-20

Upgrade

JP Morgan

Neutral → Overweight

$116

Apr-16-20

Initiated

Goldman

Buy

$151

Mar-12-20

Upgrade

JP Morgan

Underweight → Neutral

$88

Jan-28-20

Initiated

BMO Capital Markets

Market Perform

Jan-27-20

Initiated

BMO Capital Markets

Market Perform

Sep-24-19

Upgrade

Guggenheim

Neutral → Buy

$116

Sep-09-19

Upgrade

Jefferies

Hold → Buy

$89 → $105

Aug-02-19

Downgrade

JP Morgan

Neutral → Underweight

$85

Jul-18-19

Initiated

Deutsche Bank

Hold

$86

Jun-19-19

Downgrade

B. Riley FBR

Buy → Neutral

$60 → $92

Jun-07-19

Downgrade

Guggenheim

Buy → Neutral

Jun-05-19

Reiterated

H.C. Wainwright

Buy

$84 → $117

Feb-27-21 09:23AM	15 Fastest Growing Biotech Companies in the US Insider Monkey
Feb-18-21 04:15PM	Mirati Therapeutics To Present At Upcoming Healthcare Conferences PR Newswire
Feb-10-21 07:00AM	MD Anderson And Mirati Therapeutics Announce KRAS Strategic Research And Development Collaboration In Solid Tumors PR Newswire
Feb-08-21 05:47AM	Investors Who Bought Mirati Therapeutics (NASDAQ:MRTX) Shares Five Years Ago Are Now Up 932% Simply Wall St.
Feb-04-21 04:30PM	Mirati Therapeutics To Present At Guggenheim Healthcare Talks 2021 Oncology Days PR Newswire
Jan-26-21 12:00PM	Qorvo Trading Near Top Of Buy Range With Earnings On Tap Investor's Business Daily
07:30AM	5G Stocks To Buy And Watch: Apple Earnings Due Amid 5G 'Supercycle' Expectations Investor's Business Daily
Jan-20-21 08:00AM	Qorvo® to Webcast Quarterly Earnings Conference Call on February 3, 2021 GlobeNewswire
Jan-18-21 06:43AM	Qorvo, Inc.'s (NASDAQ:QRVO) Stock's On An Uptrend: Are Strong Financials Guiding The Market? Simply Wall St.
Jan-12-21 08:00AM	Qorvo® Unleashes Full 6 GHz Performance with New Wi-Fi 6E FEMs GlobeNewswire
Jan-11-21 08:00AM	Qorvo® Launches First Fully Integrated Automotive eCall Switch with Industry-Leading Reliability and Performance GlobeNewswire
Jan-07-21 04:43PM	Rogers Corp. Stock Heats Up With 83 Relative Strength Rating Investor's Business Daily
03:30PM	Nasdaq Leads Broad Advance As These 3 Top Stocks Break Out; Time To Sell Twitter Stock? Investor's Business Daily
08:26AM	Dow Jones Futures Rise: Congress Certifies Biden Win After Pro-Trump Mob Stormed Capitol Hill; These 5 Stocks Are Buys Investor's Business Daily
Jan-06-21 03:24PM	Dow Jones Pares Earlier Gains As Trump Rioters Storm Capitol; These Stocks Break Out Investor's Business Daily
01:52PM	Dow Surges As Senate Result Raises New Stimulus Hopes; Breakouts Flourish As Tesla Hits Record Investor's Business Daily
Jan-05-21 10:19AM	Qorvo Ascends Toward Buy Point Investor's Business Daily Video
Jan-04-21 05:56PM	The Coming 5G Boom Is Not Fully Priced in These 2 Stocks, Say Analysts TipRanks
05:19PM	Mirati Therapeutics To Present At The 39th Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-28-20 06:37AM	Is Now The Time To Put Qorvo (NASDAQ:QRVO) On Your Watchlist? Simply Wall St.
Dec-24-20 10:50AM	Is MRTX A Good Stock To Buy According To Hedge Funds? Insider Monkey
08:26AM	Dow Jones Futures: Stock Market Rally Takes Trump Veto Threat In Stride; China Launches Alibaba Probe, 6 Chip Stocks Near Buy Points Investor's Business Daily
Dec-23-20 07:51PM	Dow Jones Futures: Stock Market Rally Takes Trump's Stimulus Deal Veto Threat In Stride; AMD, Apple Chipmakers Near Buy Points Investor's Business Daily
12:01PM	Dow Jones Rallies Despite Trump Veto Threat; Apple Approaches New Buy Point, While Tesla Reverses Higher Investor's Business Daily
Dec-22-20 04:40PM	Qorvo, IBD Stock Of The Day, Riding 5G Wireless Upgrade Wave Investor's Business Daily
10:15AM	Qorvo Ascends Toward Buy Point Investor's Business Daily Video
Dec-19-20 02:44PM	10 Best Biotech Stocks to Invest In According To Billionaire Biotech Hedge Fund Insider Monkey
Dec-15-20 08:53AM	Zomedica to Remain Domiciled in Canada GlobeNewswire
Dec-08-20 01:42PM	Rogers Clears Technical Benchmark, Hitting 80-Plus RS Rating Investor's Business Daily
12:32PM	Is QRVO A Good Stock To Buy Now? Insider Monkey
Dec-07-20 06:01AM	Zomedica Completes Internal Launch Team for Upcoming TRUFORMA Commercialization GlobeNewswire
04:43AM	We Like These Underlying Trends At Qorvo (NASDAQ:QRVO) Simply Wall St.
Dec-04-20 04:27PM	Qualcomm Stock Surges On Strong 5G Wireless Chip Demand Investor's Business Daily
11:31AM	Why Is Mirati (MRTX) Down 2.2% Since Last Earnings Report? Zacks
Dec-02-20 08:00AM	Qorvo® to Present at Barclays Global Technology, Media and Telecommunications Virtual Conference GlobeNewswire
Dec-01-20 06:58AM	Dow Jones Futures: Tesla Rallies On S&P 500 Update; Zoom Falls On Earnings; Apple, AMD Lead Stock Market Rally Investor's Business Daily
06:33AM	Dow Jones Futures: Tesla Rallies On S&P 500 Update; Zoom Falls On Earnings; Apple, AMD Lead Stock Market Rally Investor's Business Daily
Nov-28-20 08:40AM	Dow Jones Futures: Stock Market Rally Flashes Mixed Signals; Watch Apple, Nio, Zoom Video, CrowdStrike Investor's Business Daily
08:00AM	AMD, Apple Chipmakers Qorvo, Qualcomm Lead 5 Stocks Near Buy Points Investor's Business Daily
Nov-24-20 08:00AM	Qorvo® to Present at Wells Fargo TMT Virtual Summit GlobeNewswire
Nov-23-20 04:30PM	Mirati Therapeutics To Participate In The 2020 Evercore ISI HealthCONx Conference PR Newswire
08:11AM	Dow Jones Futures Rise On Latest Coronavirus News; Qualcomm Near Buy Point In Stock Market Rally; Apple Looks Tired Investor's Business Daily
Nov-22-20 05:22PM	Stock Market Rally: Qualcomm Near Buy Point; Apple Looks Tired As Dow Futures Loom Investor's Business Daily
Nov-20-20 04:27PM	Qorvo, IBD Stock Of The Day, Is Forming This Bullish Stock Chart Pattern Investor's Business Daily
11:33AM	Qorvo Sets Up Tight Entry Investor's Business Daily Video
Nov-19-20 02:26PM	Qorvo CEO Bob Bruggeworth Elected Chair of Semiconductor Industry Association PR Newswire
Nov-17-20 10:04AM	Qorvo Trades Tightly Investor's Business Daily Video
Nov-16-20 03:13AM	What Can We Learn About Qorvo's (NASDAQ:QRVO) CEO Compensation? Simply Wall St.
Nov-12-20 10:35AM	Cree Shows Market Leadership With Jump To 83 RS Rating Investor's Business Daily
Nov-08-20 09:44AM	Analyst Estimates: Here's What Brokers Think Of Mirati Therapeutics, Inc. (NASDAQ:MRTX) After Its Third-Quarter Report Simply Wall St.
Nov-06-20 02:18PM	Barnes & Noble Education and MobileIron See Activist Action Barrons.com
10:50AM	Power Integrations Earns 81 RS Rating, Showing Rising Market Leadership Investor's Business Daily
Nov-05-20 04:30PM	Mirati Therapeutics To Participate In The 29th Annual Credit Suisse Virtual Healthcare Conference PR Newswire
08:00AM	Qorvo® Wins U.S. Government Project to Create Advanced, State-of-the-Art, RF Semiconductor Packaging Center GlobeNewswire
07:30AM	Qorvo® Acquires UWB Software Provider 7Hugs Labs S.A.S. GlobeNewswire
Nov-04-20 07:05PM	Mirati (MRTX) Reports Q3 Loss, Tops Revenue Estimates Zacks +6.17%
05:05PM	Qualcomm Phones In Beat-And-Raise Report As 5G Kicks Into High Gear Investor's Business Daily
04:15PM	Mirati Therapeutics Reports Third Quarter 2020 Financial Results And Recent Business Highlights PR Newswire
04:00PM	Qorvo® Announces Fiscal 2021 Second Quarter Financial Results GlobeNewswire
Nov-03-20 12:21PM	Were Hedge Funds Right About Loading Up On Mirati Therapeutics, Inc. (MRTX)? Insider Monkey
Oct-30-20 05:09PM	Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares PR Newswire
10:20AM	Microchip Technology Earns RS Rating Upgrade On An IBD Stock Checkup Investor's Business Daily
08:39AM	Why Mirati Therapeutics (MRTX) Might Surprise This Earnings Season Zacks
Oct-29-20 09:13AM	Need To Know: The Consensus Just Cut Its Mirati Therapeutics, Inc. (NASDAQ:MRTX) Estimates For 2020 Simply Wall St. +8.76%
Oct-28-20 06:51PM	Amgens Earnings and Sales Climb, Driven by Its Biosimilars Barrons.com
04:48AM	Mirati Therapeutics Sets Share Price For $800M Public Offering SmarterAnalyst
Oct-27-20 08:04PM	Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock PR Newswire +6.35%
07:53AM	Better Buy: Amgen vs. Mirati Therapeutics Motley Fool
03:49AM	Mirati To Launch $700M Public Offering; Shares Fall After-Hours SmarterAnalyst
Oct-26-20 04:46PM	Mirati Therapeutics Announces Proposed Public Offering of Common Stock PR Newswire +9.15%
04:23PM	Tiny Mirati Therapeutics Gets Jump On Giant Amgen In Cancer Drug Investor's Business Daily
03:13PM	Calculating The Fair Value Of Qorvo, Inc. (NASDAQ:QRVO) Simply Wall St.
12:31PM	Mirati (MRTX) Expected to Beat Earnings Estimates: Should You Buy? Zacks
12:22PM	Were Hedge Funds Right About Crowding Into Qorvo Inc (QRVO)? Insider Monkey
11:32AM	Why Mirati Therapeutics Stock Is Taking Off Today Motley Fool
03:02AM	Mirati Reports Promising Anti-Tumor Activity For Adagrasib SmarterAnalyst
Oct-25-20 10:45AM	Mirati Therapeutics Reports Investigational Adagrasib (MRTX849) Preliminary Data Demonstrating Tolerability and Durable Anti-Tumor Activity as well as Initial MRTX1133 Preclinical Data PR Newswire
Oct-24-20 06:00AM	Cancer Meeting Could Ignite These Biotech Stocks Barrons.com
Oct-23-20 12:52PM	Hedge Fund Darling Miratis $5 Billion Stock Rally Set for Test Bloomberg
Oct-21-20 05:17PM	Qorvo: Stock To Watch With Earnings On Deck Investor's Business Daily
01:16PM	ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Mirati Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
08:00AM	Qorvo® to Webcast Quarterly Earnings Conference Call on November 4, 2020 GlobeNewswire
Oct-17-20 01:57AM	Qorvo, Inc. -- Moody's rates Qovo's new Senior Notes at Ba1 Moody's
Oct-15-20 04:30PM	Mirati Therapeutics To Present Data During The 2020 EORTC-NCI-AACR International Virtual Conference On Molecular Targets And Therapeutics (ENA) PR Newswire
Oct-14-20 04:06PM	INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Mirati Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Oct-13-20 04:08PM	Apple Introduces 5G iPhone 12 Handsets, HomePod Mini Speaker Investor's Business Daily
Oct-08-20 04:28PM	Taiwan Semiconductor News Brightens Outlook For Chip Earnings Season Investor's Business Daily
Oct-06-20 02:55PM	INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Mirati Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
01:56PM	If You Had Bought Qorvo (NASDAQ:QRVO) Stock Five Years Ago, You Could Pocket A 207% Gain Today Simply Wall St.
09:48AM	Amgen Says Study Results on Its Novel Cancer Drug Were Positive Barrons.com
Oct-05-20 02:06PM	Mirati Therapeutics, Inc. (NASDAQ:MRTX) Shares Could Be 37% Below Their Intrinsic Value Estimate Simply Wall St.
08:00AM	Qorvo® Ultra-Wideband Helps the World Get Back to Work GlobeNewswire
Oct-01-20 04:40PM	Apple iPhone Sales Could Get Lift As Huawei Smartphone Production Stalls Investor's Business Daily
11:38AM	Apple iPhone Sales Could Get Lift As Huawei Smartphone Production Stalls Investor's Business Daily
Sep-29-20 11:30AM	Qorvo Announces Closing of $700 Million Senior Notes Offering GlobeNewswire
Sep-18-20 04:16PM	High Hopes for Amgen and Gilead at Europes Biggest Cancer Research Conference Barrons.com
04:10PM	Qorvo, Inc. -- Moody's announces completion of a periodic review of ratings of Qorvo, Inc. Moody's
08:00AM	Mirati Therapeutics Presents Phase 2 Data On Sitravatinib In Combination With Nivolumab In Urothelial Cancer At ESMO Virtual Congress PR Newswire
Sep-17-20 08:01AM	Boehringer Ingelheim And Mirati Therapeutics Announce Clinical Collaboration To Study BI 1701963, A SOS1::pan-KRAS Inhibitor In Combination With MRTX849, A KRAS G12C Selective Inhibitor PR Newswire
Sep-15-20 05:00PM	Qorvo Announces Pricing of $700 Million Senior Notes Offering GlobeNewswire +8.17%

Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase I/II clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; and sitravatinib, a spectrum-selective kinase inhibitor that is in Phase II clinical trial for the treatment of NSCL cancer, as well as a KRAS G12D inhibitor program, which is in preclinical development. It has a collaboration and license agreement with BeiGene, Ltd. to develop, manufacture, and commercialize sitravatinib; and a clinical collaboration agreement with Novartis Pharmaceuticals Corporation. The company also has a strategic research and development collaboration with the University of Texas MD Anderson Cancer Center to expand the evaluation of MRTX849, as well as MRTX1133, a G12D inhibitor in preclinical development as monotherapy for cancer. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Faga Daniel	EVP, Chief Operating Officer	Feb 02	Option Exercise	114.33	1,340	153,202	31,978	Feb 03 05:09 PM
CARTER BRUCE L A	Director	Feb 02	Option Exercise	6.78	2,250	15,255	5,725	Feb 03 05:08 PM
CARTER BRUCE L A	Director	Feb 02	Sale	191.12	2,250	430,018	3,475	Feb 03 05:08 PM
Faga Daniel	EVP, Chief Operating Officer	Feb 02	Sale	194.38	1,340	260,469	30,638	Feb 03 05:09 PM
Martinez Maria E	Director	Jan 29	Option Exercise	39.76	7,500	298,200	10,975	Feb 01 09:47 PM
Martinez Maria E	Director	Jan 29	Sale	203.54	7,500	1,526,584	3,475	Feb 01 09:47 PM
BAUM CHARLES M	President & CEO	Jan 26	Option Exercise	5.40	2,292	12,377	112,714	Jan 28 05:45 PM
Johnson Craig A	Director	Jan 21	Option Exercise	20.54	15,000	308,100	18,475	Jan 25 04:31 PM
Johnson Craig A	Director	Jan 21	Sale	211.55	15,000	3,173,203	3,475	Jan 25 04:31 PM
BAUM CHARLES M	President & CEO	Jan 19	Option Exercise	27.00	3,245	87,615	110,422	Jan 20 06:17 PM
REED VICKIE S	SVP, Chief Accounting Officer	Jan 07	Sale	216.33	241	52,135	7,471	Jan 08 07:57 PM
Hickey Benjamin	EVP, Chief Commercial Officer	Jan 07	Sale	216.33	2,078	449,525	19,789	Jan 08 07:46 PM
Faga Daniel	EVP, Chief Operating Officer	Jan 07	Sale	216.33	2,625	567,854	23,615	Jan 08 07:15 PM
REED VICKIE S	SVP, Chief Accounting Officer	Jan 06	Sale	210.39	538	113,190	7,712	Jan 08 07:57 PM
Christensen Jamie	EVP, Chief Scientific Officer	Jan 06	Sale	210.39	1,459	306,961	47,262	Jan 08 07:15 PM
BAUM CHARLES M	President & CEO	Jan 06	Sale	210.39	4,511	949,066	87,512	Jan 08 07:14 PM
BAUM CHARLES M	President & CEO	Dec 18	Option Exercise	8.49	40,000	339,600	142,023	Dec 21 06:28 PM
BAUM CHARLES M	President & CEO	Dec 18	Sale	234.48	40,000	9,379,114	102,023	Dec 21 06:28 PM
FUCHS HENRY J	Director	Dec 15	Option Exercise	20.54	10,000	205,400	12,000	Dec 16 05:37 PM
FUCHS HENRY J	Director	Dec 15	Sale	233.39	10,000	2,333,907	2,000	Dec 16 05:37 PM
CARTER BRUCE L A	Director	Dec 14	Option Exercise	6.78	2,250	15,255	4,250	Dec 16 05:37 PM
GREY MICHAEL G	Director	Dec 14	Option Exercise	16.84	10,900	183,556	15,156	Dec 16 05:36 PM
GREY MICHAEL G	Director	Dec 14	Sale	245.44	10,900	2,675,345	4,256	Dec 16 05:36 PM
CARTER BRUCE L A	Director	Dec 14	Sale	246.28	2,250	554,127	2,000	Dec 16 05:37 PM
Christensen Jamie	EVP, Chief Scientific Officer	Nov 02	Option Exercise	8.32	10,879	90,493	48,721	Nov 04 05:59 PM
Boxer Capital, LLC	10% Owner	Oct 30	Option Exercise	0.00	400,003	400	1,765,562	Oct 30 09:54 PM
Boxer Capital, LLC	10% Owner	Oct 30	Sale	202.00	400,000	80,800,000	216,288	Oct 30 09:54 PM
Braslyn Ltd.	10% Owner	Oct 29	Option Exercise	0.00	104,565	105	3,135,967	Oct 30 09:53 PM
Braslyn Ltd.	10% Owner	Oct 29	Sale	213.33	104,564	22,306,891	3,031,402	Oct 30 09:53 PM
Braslyn Ltd.	10% Owner	Oct 28	Option Exercise	0.00	295,438	295	3,135,968	Oct 30 09:53 PM
Braslyn Ltd.	10% Owner	Oct 28	Sale	206.57	295,436	61,027,546	2,840,530	Oct 30 09:53 PM
CARTER BRUCE L A	Director	Aug 11	Option Exercise	6.78	2,250	15,255	4,250	Aug 13 04:03 PM
CARTER BRUCE L A	Director	Aug 11	Sale	126.41	2,250	284,428	2,000	Aug 13 04:03 PM
FUCHS HENRY J	Director	Aug 10	Option Exercise	20.54	10,000	205,400	12,000	Aug 11 05:36 PM
FUCHS HENRY J	Director	Aug 10	Sale	131.38	10,000	1,313,783	2,000	Aug 11 05:36 PM
Braslyn Ltd.	10% Owner	Jun 12	Option Exercise	0.00	600,006	600	3,135,972	Jun 16 05:03 PM
Braslyn Ltd.	10% Owner	Jun 12	Sale	69.00	600,000	41,400,000	2,535,966	Jun 16 05:03 PM
CARTER BRUCE L A	Director	May 18	Option Exercise	6.78	4,000	27,120	6,000	May 20 05:10 PM
CARTER BRUCE L A	Director	May 18	Sale	106.86	4,000	427,440	2,000	May 20 05:10 PM
CHEN ISAN	EVP, Chief Medical Officer	May 11	Option Exercise	24.99	33,334	833,017	72,735	May 13 04:18 PM
CHEN ISAN	EVP, Chief Medical Officer	May 11	Sale	105.00	33,334	3,500,070	39,401	May 13 04:18 PM
BAUM CHARLES M	President & CEO	Apr 27	Option Exercise	5.40	557	3,008	107,023	Apr 28 08:49 PM
Johnson Craig A	Director	Apr 20	Option Exercise	25.84	15,000	387,600	17,000	Apr 21 05:26 PM
Johnson Craig A	Director	Apr 20	Sale	93.00	15,000	1,395,000	2,000	Apr 21 05:26 PM
BAUM CHARLES M	President & CEO	Apr 17	Option Exercise	8.49	40,000	339,600	146,466	Apr 20 04:59 PM
BAUM CHARLES M	President & CEO	Apr 17	Sale	90.33	40,000	3,613,109	106,466	Apr 20 04:59 PM
BAUM CHARLES M	President & CEO	Mar 27	Option Exercise	5.40	2,291	12,371	106,466	Mar 30 05:52 PM
Christensen Jamie	EVP, Chief Scientific Officer	Mar 26	Option Exercise	15.51	8,058	124,983	32,842	Mar 27 05:37 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience